Article

Bbarrons.com on 2021-06-08 16:53

Eli Lilly May Be a Big Winner From FDA's Alzheimer's Decision4 min

The approval of a Biogen drug has raised hope that Eli Lilly could seek approval for its own treatment far sooner than expected.

Mizuho-machi

Related news

BEli Lilly Stock Soared on Alzheimer's Hopes. Now Wall Street Has Doubts.3 min read barrons.com
Wall Street
BEli Lilly Executives Enthusiastic About Alzheimer's Drug, Analyst Says barrons.com
Phase 2
BStreet Shrugs Off FDA's Call for Probe of Alzheimer's Drug Approval3 min read barrons.com
Wall Street
BEli Lilly Is Asking the FDA to Approve Its Alzheimer's Therapy4 min read barrons.com
BEli Lilly Will Unveil Alzheimer's Drug Data Next Week. What to Watch.barrons.com
Phase 2
BEli Lilly Makes a Case For Its Alzheimer's Drug as Shares Drop barrons.com
Phase 2
BEli Lilly Offers More Positive Data on Its Alzheimer's Drug. What Investors Need to Know.barrons.com
Phase 2
WAlzheimer's drug candidate from Eli Lilly delivers 'the kind of efficacy that's never been seen before'wraltechwire.com
Eli Lilly: Experimental Alzheimer's drug works The Salt Lake Tribune
Amsterdam , Mayo Clinic , Washington , Indianapolis
Eli Lilly says experimental drug slows Alzheimer's worsening timesfreepress.com
Indianapolis
GEli Lilly: Experimental Alzheimer's drug shows some benefit gaffneyledger.com
Amsterdam , Mayo Clinic
MEli Lilly and AstraZeneca to co-develop Alzheimer's Disease treatment marketwatch.com
BAlzheimer's Drugs May Be a Big-Pharma Payday. Lilly and Biogen Are Facing Off. 4 min read barrons.com
San Francisco
BThe FDA's Next Call on an Alzheimer's Drug Is Due This Week 3 min read barrons.com
Eli Lilly michronicleonline.com
Puerto Rico
MEli Lilly hikes quarterly dividend 15%1 min read marketwatch.com
BEli Lilly Stock Falls After Alzheimer's Drug Results Disappoint Wall Street barrons.com
Wall Street
Experimental Alzheimer's drug slows cognitive declines in large trial, drugmaker Eli Lilly says post-gazette.com